AURORA SPINE CORP (ASG.CA) Stock News

TSX-V:ASG - TSX Venture Exchange - CA05206X1087 - Common Stock - Currency: CAD

0.34 +0.02 (+4.62%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ASG.CA Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Aurora Spine Corporation

Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference

6 days ago - By: Aurora Spine Corporation

Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference

12 days ago - By: Aurora Spine Corporation

Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System

12 days ago - By: Aurora Spine Corporation

Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System

a month ago - By: Aurora Spine Corporation

Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™

a month ago - By: Aurora Spine Corporation

Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™

a month ago - By: Aurora Spine Corporation

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

a month ago - By: Aurora Spine Corporation

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

2 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

2 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

2 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Record First Quarter Financial Results

2 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results

2 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results

3 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results

3 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results

3 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results

3 months ago - By: Aurora Spine Corporation

Aurora Spine Announces the Resignation of Board Director James Snow

3 months ago - By: Aurora Spine Corporation

Aurora Spine Announces the Resignation of Board Director James Snow

4 months ago - By: Aurora Spine Corporation

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

4 months ago - By: Aurora Spine Corporation

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

4 months ago - By: Aurora Spine Corporation

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

4 months ago - By: Aurora Spine Corporation

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

4 months ago - By: Aurora Spine Corporation

Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting

4 months ago - By: Aurora Spine Corporation

Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting

4 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

4 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

6 months ago - By: Aurora Spine Corporation

Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts

6 months ago - By: Aurora Spine Corporation

Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts

9 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results

9 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results

9 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Third Quarter 2024 Financial Results

9 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System

9 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System

10 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

10 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

10 months ago - By: Aurora Spine Corporation

Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut

10 months ago - By: Aurora Spine Corporation

Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut

11 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets

11 months ago - By: Aurora Spine Corporation

Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets

a year ago - By: Aurora Spine Corporation

Aurora Spine Corporation Announces Second Quarter 2024 Financial Results